HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuo Hamamoto Selected Research

Non-Histone Chromosomal Proteins

9/2012Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuo Hamamoto Research Topics

Disease

31Neoplasms (Cancer)
01/2022 - 09/2000
21Stomach Neoplasms (Stomach Cancer)
07/2021 - 09/2000
16Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 05/2005
13Neoplasm Metastasis (Metastasis)
01/2022 - 09/2000
12Disease Progression
01/2021 - 09/2000
11Esophageal Squamous Cell Carcinoma
01/2022 - 11/2013
10Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 06/2011
6Neutropenia
02/2021 - 10/2013
6Pancreatic Neoplasms (Pancreatic Cancer)
10/2018 - 06/2010
4Renal Cell Carcinoma (Grawitz Tumor)
07/2021 - 01/2011
4Infections
02/2021 - 01/2011
4Adenocarcinoma
06/2020 - 09/2012
4Carcinoma (Carcinomatosis)
01/2017 - 05/2005
4Anorexia
12/2013 - 06/2012
3Stomatitis
10/2021 - 01/2011
3Hand-Foot Syndrome
02/2019 - 11/2014
3Anemia
01/2019 - 04/2010
3Lymphatic Metastasis
09/2018 - 09/2000
3Diarrhea
07/2018 - 11/2014
3Hemorrhage
04/2016 - 04/2002
2Ulcerative Colitis
10/2021 - 03/2021
2Melanoma (Melanoma, Malignant)
07/2021 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 01/2020
2Enterocolitis
03/2021 - 02/2020
2Febrile Neutropenia
02/2021 - 07/2016
2Ascites
06/2020 - 01/2020
2Pneumonia (Pneumonitis)
11/2019 - 01/2011
2Hypertension (High Blood Pressure)
01/2019 - 02/2015
2Hypersensitivity (Allergy)
07/2018 - 04/2015
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2018 - 11/2016
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 11/2016
2Colonic Neoplasms (Colon Cancer)
02/2013 - 05/2011
2Fever (Fevers)
06/2012 - 12/2004
1Residual Neoplasm
01/2022
1Coinfection
10/2021
1Immediate Hypersensitivity
07/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2019
1Abscess
11/2019
1Colic (Abdominal Cramps)
01/2019

Drug/Important Bio-Agent (IBA)

17Fluorouracil (Carac)FDA LinkGeneric
02/2021 - 09/2000
15Cisplatin (Platino)FDA LinkGeneric
02/2021 - 09/2000
13NivolumabIBA
01/2022 - 01/2017
8Immune Checkpoint InhibitorsIBA
01/2022 - 07/2018
8Irinotecan (Camptosar)FDA LinkGeneric
06/2016 - 04/2008
6Docetaxel (Taxotere)FDA Link
02/2021 - 11/2013
6Capecitabine (Xeloda)FDA Link
05/2018 - 10/2010
6Bevacizumab (Avastin)FDA Link
05/2018 - 10/2010
5Paclitaxel (Taxol)FDA LinkGeneric
06/2020 - 06/2011
5Trastuzumab (Herceptin)FDA Link
01/2020 - 04/2012
4AntibodiesIBA
07/2021 - 09/2012
4PlatinumIBA
11/2019 - 06/2011
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 10/2010
4GemcitabineFDA Link
10/2018 - 06/2010
3SteroidsIBA
07/2018 - 01/2011
3InterferonsIBA
07/2018 - 06/2012
3Monoclonal AntibodiesIBA
12/2017 - 05/2009
3Sorafenib (BAY 43-9006)FDA Link
02/2015 - 01/2011
3Leucovorin (Folinic Acid)FDA Link
05/2014 - 04/2008
2pembrolizumabIBA
01/2022 - 01/2020
2CreatinineIBA
02/2021 - 01/2017
2RamucirumabIBA
06/2020 - 01/2019
2ErbB Receptors (EGF Receptor)IBA
01/2020 - 05/2009
2regorafenibIBA
01/2020 - 01/2016
2Immunoglobulin G (IgG)IBA
01/2019 - 12/2017
2Proteins (Proteins, Gene)FDA Link
12/2018 - 01/2013
2Peptides (Polypeptides)IBA
07/2018 - 04/2015
2EnzymesIBA
07/2018 - 04/2015
2Pharmaceutical PreparationsIBA
01/2017 - 02/2013
2Panitumumab (Vectibix)FDA Link
06/2016 - 05/2009
2Methotrexate (Mexate)FDA LinkGeneric
10/2013 - 09/2000
2Cetuximab (Erbitux)FDA Link
02/2013 - 06/2011
2XELOXIBA
04/2011 - 10/2010
2EverolimusFDA Link
01/2011 - 04/2010
2Complementary DNA (cDNA)IBA
06/2007 - 05/2005
1Circulating Tumor DNAIBA
01/2022
1SodiumIBA
01/2022
1Antimicrobial PeptidesIBA
10/2021
1Qingdai compoundIBA
10/2021
1Indigo Carmine (Indigo Blue)IBA
10/2021
1Serum AlbuminIBA
07/2021
1Capsules (Microcapsules)IBA
03/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2021
1tributyl phosphate (TBP)IBA
01/2021
1130-nm albumin-bound paclitaxelIBA
06/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
05/2020
1Biomarkers (Surrogate Marker)IBA
05/2020
1atezolizumabIBA
01/2020
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2019
1DesminIBA
01/2019
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2019

Therapy/Procedure

37Drug Therapy (Chemotherapy)
10/2021 - 09/2000
31Therapeutics
01/2022 - 09/2000
5Chemoradiotherapy
01/2022 - 06/2010
4Induction Chemotherapy
02/2021 - 11/2016
3Salvage Therapy
01/2022 - 06/2016
3Radiotherapy
01/2019 - 04/2016
2Lymph Node Excision (Lymph Node Dissection)
01/2019 - 09/2018
2Combination Drug Therapy (Combination Chemotherapy)
12/2013 - 10/2010
2Adjuvant Chemotherapy
05/2011 - 09/2000
1Neoadjuvant Therapy
01/2022